Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $6.86 Analyst target: $12.00 Upside: 74.93%
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
See the full interactive analysis & chart →Informational only — not investment advice.